Logo image
Se connecter
Long-Term Outcomes in Patients With Isocitrate Dehydrogenase–Mutated Grade 2 Glioma Who Never Received Adjuvant Oncological Treatment After Upfront Mapping–Based Surgical Resection
Article de revue   Avec comité de lecture

Long-Term Outcomes in Patients With Isocitrate Dehydrogenase–Mutated Grade 2 Glioma Who Never Received Adjuvant Oncological Treatment After Upfront Mapping–Based Surgical Resection

Hugues Duffau
Neurosurgery
09/2025
PMID: 40970733

Résumé

Functional outcomes Intraoperative mapping Low-grade glioma Return to work Surgery Survival

Fichiers et liens (1)

url
Find in HALAfficher

Indicateurs

1 Consultations de la notice

Détails

Logo image